Aktie A3DV48 ORBUSNEICH MEDICAL GROUP HOLDINGS LIMITED
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen OrbusNeich Medical Group Holdings Limited

Aktien

A3DV48

KYG6773B1005

6929

Markt geschlossen - Hong Kong S.E.
Andere Börsenplätze
 10:08:42 28.06.2024 		% 5 Tage % 1. Jan.
4.24 HKD -3.20% Intraday Chart für OrbusNeich Medical Group Holdings Limited -3.42% -39.86%
06.06. OrbusNeich Medical Group Holdings Limited genehmigt Schlussdividende für das Jahr bis zum 31. Dezember 2023, zahlbar am oder um den 28. Juni 2024 CI
07.03. Gewinn der OrbusNeich Medical Group steigt im Jahr 2023 um 144 MT

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
OrbusNeich Medical Group Holdings Limited Approves Final Dividend for the Year Ended December 31, 2023, Payable on or Around June 28, 2024
OrbusNeich's Joint Venture Kicks Off TricValve Clinical Trial in Mainland China
OrbusNeich Medical Group’s Profit Up 144% in 2023
OrbusNeich Medical Group Holdings Limited Proposes Final Dividend for the Year Ended December 31, 2023, Payable on 28 June 2024
OrbusNeich Achieves Record-High Revenue and Net Profit of US$154 Million and US$45.1 Million Respectively, Recommends Final Dividend Payment of HK10 cents per Share
OrbusNeich Medical Group Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023
OrbusNeich Medical Seeks M&A Opportunities
OrbusNeich Medical Group Holdings Limited acquired SJ Medicare Co. Ltd.
OrbusNeich Expects More Than Doubling of 2023 Profit
Certain Ordinary Shares of OrbusNeich Medical Group Holdings Limited are subject to a Lock-Up Agreement Ending on 22-DEC-2023.
OrbusNeich Medical Subsidiary Buys 84% Stake in Indonesian Medical Device Maker
OrbusNeich Acquires 84% Stake in an Indonesian Distributor for Approximately US$15 Million
OrbusNeich Medical to Acquire Eucatech for 2.4 Million Euros
OrbusNeich Adds Drug-eluting Balloons in Product Portfolio Through Acquisition of Eucatech AG
OrbusNeich Medical Group Holdings Limited acquired Eucatech AG for ?2.4 million.
OrbusNeich Medical Extends Term of Exclusive US Distributor of Products to 2027
Orbusneich Medical Group Holdings Limited and Cardiovascular Systems, Inc. Enters into an Amendment to Distribution Agreement
OrbusNeich Medical Group Holdings Limited(SEHK:6929) added to S&P Global BMI Index
OrbusNeich Medical Group Holdings Limited Announces Retirement of Ching Chung John Chow from the Group of All Executive Roles and Has Been Re-Designated as Non-Executive Director with effect from September 7, 2023
OrbusNeich Medical Group Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2023
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A3DV48 Aktie
  4. Nachrichten OrbusNeich Medical Group Holdings Limited
  5. Andere Sprachen